Results 161 to 170 of about 280,456 (250)

Clinical practice recommendations on lipoprotein apheresis for children with homozygous familial hypercholesterolaemia: An expert consensus statement from ERKNet and ESPN.

Atherosclerosis
M. D. Reijman, D. Kusters, Jaap W. Groothoff, K. Arbeiter, E. Dann, L. D. de Boer, Sarah D. de Ferranti, Antonio Gallo, Susanne Greber-Platzer, Jacob Hartz, Lisa C. Hudgins, D. Ibarretxe, M. Kayıkçıoğlu, Reinhard Klingel, G. Kolovou, Jun Oh, R. Planken, C. Stefanutti, C. Taylan, A. Wiegman, C. P. Schmitt   +20 more
semanticscholar   +1 more source

Long-term lipoprotein apheresis reduces cardiovascular events in high-risk patients with isolated lipoprotein(a) elevation.

Journal of Clinical Lipidology
F. Schumann, U. Kassner, D. Spira, Felix F. Zimmermann, T. Bobbert, Elisabeth Steinhagen-Thiessen, Tim Hollstein   +6 more
semanticscholar   +1 more source

FP486CHARACTERIZATION OF THE TRANSCRIPTOMIC PROFILE OF PERIPHERAL BLOOD MONONUCLEAR CELLS (PBMCS) OF PATIENTS WITH FAMILIAL HYPERCHOLESTEROLEMIA (FH) TREATED WITH LOW-DENSITY LIPOPROTEIN-APHERESIS (LDL-A) [PDF]

, 2015
Simona Simone, Annarita Chieti, Nicla Campobasso, Marica Strippoli, Giuseppe Grandaliano, Matteo Accetturo, Paola Pontrelli, Loreto Gesualdo, Giovanni Pertosa   +8 more
openalex   +1 more source

Lipoprotein(a) apheresis restores coronary microcirculation in refractory angina

Revista Portuguesa de Cardiologia, 2022
Francesco Sbrana, Beatrice Dal Pino, Giovanni Donato Aquaro, Federico Bigazzi, Giuseppe Vergaro, Tiziana Sampietro   +5 more
doaj   +1 more source

Real-World Efficacy of Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors (PCSK9i) in Heterozygous Familial Hypercholesterolemia Patients Referred for Lipoprotein Apheresis. [PDF]

Med Sci Monit, 2021
Matta A, Bongard V, Bouisset F, Taraszkiewicz D, Rabès JP, Ferrières J.   +5 more
europepmc   +1 more source

Application of Lipoprotein Apheresis in Drug-Resistant Nephrotic Syndrome

, 2020
Miguel Brochado Pinto Silva Queirós
openalex   +2 more sources

Lipoprotein Apheresis for Lipoprotein(a)-Associated Cardiovascular Disease [PDF]

, 2016
E. Roeseler, Ulrich Julius, Franz Heigl, Ralf Spitthoever, Dennis Heutling, Paul Breitenberger, Josef Leebmann, Walter Lehmacher, Pia R. Kamstrup, Børge G. Nordestgaard, Winfried Maerz, Asma Noureen, Konrad Schmidt, Florian Kronenberg, Andreas Heibges, Reinhard Klingel, Volker Schettler, Thomas Benzing, Hildegard Christ, S. Wehner, Ines Schulz-Merkel, Ralf Kuehn, Albrecht Wagner, W Dschietzig, Claudia Ernst, Michael Koziolek, Johannes Bunia, Peter Kulzer, Klaus-Dieter Kraenzle, M. Toelle, Gerhard Riechers, Christine Kuehnel, Tobias A. Marsen, Christina Saehn, J Ringel, Harald Messner, Andreas Oehring, Carsten Schuerfeld, Michael Wintergalen, Volker Schettler, Falko Neumann, Harald Kaul, Martin Haesner, J. Paßfall, Andrea Benschneider, Stefan Heidenreich, Winfried März, Ruediger Klaes, Priska Binner, Hans Dieplinger, Gertraud Erhart, Cordula Fassbender, Hildegard Christ   +52 more
openalex   +1 more source

Alirocumab in patients with heterozygous familial hypercholesterolaemia undergoing lipoprotein apheresis: the ODYSSEY ESCAPE trial [PDF]

, 2016
Patrick M. Moriarty, Klaus G. Parhofer, Stephan P. Babirak, Marc-Andre Cornier, P. Barton Duell, Bernd Hohenstein, Josef Leebmann, Wolfgang Ramlow, Volker Schettler, Vinaya Simha, Elisabeth Steinhagen‐Thiessen, Paul D. Thompson, Anja Vogt, Berndt von Stritzky, Yunling Du, Garen Manvelian   +15 more
openalex   +1 more source

Reduced Oxidative Susceptibility of Lp(a) and LDL Fractions as a Pleiotropic Effect of Lipoprotein Apheresis in Patients with Elevated Lp(a) and ASCVDs. [PDF]

Int J Mol Sci
Krzesińska A, Marlęga-Linert J, Chyła-Danił G, Marcinkowska M, Rogowska P, Stumska K, Fijałkowski M, Gruchała M, Jankowski M, Mickiewicz A, Kuchta A.   +10 more
europepmc   +1 more source

Lipoprotein (a), an independent cardiovascular risk marker [PDF]

, 2016

core   +1 more source